VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 510 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2014. The put-call ratio across all filers is 1.37 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $6,000 | 0.0% | 256 | -16.3% | 0.00% | 0.0% |
| Q2 2016 | $6,000 | -25.0% | 306 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $8,000 | -80.5% | 306 | -24.6% | 0.00% | -80.0% |
| Q4 2015 | $41,000 | -49.4% | 406 | -10.4% | 0.01% | -50.0% |
| Q3 2015 | $81,000 | -9.0% | 453 | +12.4% | 0.01% | 0.0% |
| Q2 2015 | $89,000 | +17.1% | 403 | +5.8% | 0.01% | +11.1% |
| Q1 2015 | $76,000 | +90.0% | 381 | +35.6% | 0.01% | +80.0% |
| Q4 2014 | $40,000 | +8.1% | 281 | 0.0% | 0.01% | 0.0% |
| Q3 2014 | $37,000 | +5.7% | 281 | 0.0% | 0.01% | +25.0% |
| Q2 2014 | $35,000 | -5.4% | 281 | 0.0% | 0.00% | -33.3% |
| Q1 2014 | $37,000 | +12.1% | 281 | 0.0% | 0.01% | +20.0% |
| Q4 2013 | $33,000 | +13.8% | 281 | 0.0% | 0.01% | +25.0% |
| Q3 2013 | $29,000 | +31.8% | 281 | +9.8% | 0.00% | +33.3% |
| Q2 2013 | $22,000 | – | 256 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |